OMB Individually Reported
BioPlex 2200 ANA Screen with Medical Decision Support Software for Use with BioPlex 2200 Multi-Analyte Detection System
High riskExact public inventory row
Description
The BioPlex 2200 Medical Decision Support Software (MDSS) is a pattern recognition algorithm that can enhance the performance of the Antinuclear Antibody (ANA) Screening associated diagnostic patterns, among its multiple assay results.
Detailed example
The MDSS can suggest one or more possible disease associations after identifying patterns from antibody results.
AI / analytics pattern
Classical/Predictive Machine Learning: Models trained on data to make predictions or classifications based on identified patterns or relationships.
Automation level / stage
c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.
Expected benefit
Support antibody screening procedures.
Controls / human review
ATO: Not reported; PIA: Not published